Efficacy and safety of immune checkpoint inhibitors combined with recombinant human endostatin and chemotherapy as the first-line treatment of advanced non-small-cell lung cancer Table 1
收藏数据链接：
官方服务：
资源简介：
Efficacy and safety of immune checkpoint inhibitors combined with recombinant human endostatin and chemotherapy as the first-line treatment of advanced non-small-cell lung cancer Table 1
提供机构：
Taylor & Francis创建时间：
2023-04-14
